Thomas J. Schall, Ph.D.
Board Member
Immuneering Corp (IMRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas J. Schall, Ph.D.
Thomas J. Schall, Ph.D. is recorded as Board Member at Immuneering Corp (IMRX). Immuneering Corp reported in an 8-K filed March 14, 2024 that Thomas J. Schall, Ph.D. was appointed Class I Director, effective March 11, 2024.
“On March 11, 2024, the Board of Directors of Immuneering Corporation ("we," "our" and "us") appointed Thomas J. Schall, Ph.D. to serve as a member of our Board of Directors as a Class I Director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-03-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immuneering Corp
Other people whose current roles at this company are on record from its filings.
- Benjamin Zeskind CEO, Board Member
- Andrew Gengos CFO
- Biren Amin CFO
- Michael D. Bookman General Counsel
- Mallory Morales Chief Accounting Officer
- Laurie B. Keating Board Member
- Peter Feinberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.